四川成渝高速公路(00107.HK)擬斥14.2434億元成立項目公司 持股82%
格隆匯1月21日丨四川成渝高速公路(00107.HK)公佈,於1月21日,公司與中交建訂立出資人協議。據此,聯合體按天邛高速公路項目相關要求共同出資成立四川成邛雅高速公路有限責任公司(項目公司),項目公司的註冊資本人民幣17.37億元,其中公司將向項目公司出資人民幣14.2434億元。項目公司將分別由公司持有82%權益及由中交建持有18%權益。
公告顯示,項目公司的主要業務為高等級公路、橋樑、隧道基礎設施的開發、設計、建設、營運、養護、管理、技術諮詢及配套服務;與高等級公路配套的服務區、加油站、廣告位及倉儲設施的建設與租賃;汽車拯救及清洗。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.